Effect of Blood Pressure on Cardiovascular Outcomes and Recurrence After Catheter Ablation in Patients With Atrial Fibrillation
NCT ID: NCT06433336
Last Updated: 2024-05-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
800 participants
OBSERVATIONAL
2019-01-01
2024-05-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Catheter Ablation and Rate Control of Atrial Fibrillation in Patients With Heart Failure
NCT02846922
Prospective Cohort Study of the Risk of Recurrent Atrial Fibrillation After Radiofrequency Ablation
NCT05638841
Atrial Fibrillation Patients Treated With Catheter Ablation
NCT05266144
The Influence of Catheter Ablation for Atrial Fibrillation on Atrial Electrical
NCT03322085
Acute Cerebrovascular Events in Patients Undergoing Catheter Ablation
NCT05694273
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Effect of blood pressure on cardiovascular outcomes and recurrence after catheter ablation in patien
Atrial Fibrillation Recurrence Pulmonary Vein Isolation
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lanzhou University Second Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xiaowei Zhang
lanzhou university second hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
xiao wei xiaowei zhang, PHD
Role: PRINCIPAL_INVESTIGATOR
Lanzhou University Second Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lanzhou University Second Hospital
Lanzhou, Gansu, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
lanzhou university
Identifier Type: OTHER
Identifier Source: secondary_id
lanzhou university second hosp
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.